A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)

This study has been terminated.

( The primary endpoint at 15 months was not met. )

Study NCT00723411 Information provided by Diamyd Therapeutics AB

First Received: July 24, 2008 Last Updated: October 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)

No publications provided by Diamyd Therapeutics AB

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):